Endocrine Cancer News The conversion from accelerated approval to regular approval was based on data from the KEYNOTE-158 trial, the KEYNOTE-164 trial, and the KEYNOTE-051 trial.
More than 20% of US patients diagnosed with cancer during pregnancy may be unable to terminate that pregnancy due to abortion laws in their state, a new study suggests.
Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
SBRT should be offered as an alternative to surgical resection for patients with early-stage LNET, according to researchers.
Survivors of pediatric cancer have a higher rate of clonal hematopoiesis than their peers at any age, a study suggests.
Collaboration between parents and nurses is essential to the care of children with neuroblastoma receiving 131 I-MIBG, a study suggests.
Adding bevacizumab to second-line chemotherapy does not improve survival in patients with advanced neuroendocrine carcinoma, a phase 2 study suggests.
The risk of early death in AYAs with cancer depends on the type of malignancy they have as well as multiple demographic factors, a study suggests.
Centers that perform comprehensive cancer screening in a single appointment may enable earlier cancer diagnosis.
Many thyroid cancer survivors said they lacked understanding of their treatment before receiving it.
Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival, a small study suggests.
The highest risk of thyroid cancer was seen in patients with both high genetic risk and an unfavorable lifestyle.
Omburtamab is an investigational radiolabeled monoclonal antibody designed to target tumor cells that express B7-H3.
Cabozantinib prolongs progression-free survival in patients with previously treated radioiodine-refractory differentiated thyroid cancer, a phase 3 trial suggests.
Proton FLASH radiotherapy is feasible, safe, and provides pain relief for cancer patients with bone metastases, according to a first-in-human trial.
The incidence of invasive breast cancer among childhood cancer survivors decreased from the 1970s to the 1990s.
Active surveillance may be a viable management strategy for most diagnosed thyroid cancers, according to researchers.
Donafenib demonstrated efficacy in patients with progressive, locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
177 Lutetium-octreotate can improve progression-free survival vs sunitinib in patients with progressive pancreatic neuroendocrine tumors.
Etoposide plus cisplatin and irinotecan plus cisplatin remain the standard first-line chemotherapy options for advanced digestive neuroendocrine carcinoma, according to researchers.
Men tend to have a higher risk of cancer than women, and factors such as smoking, alcohol use, and diet do not appear to explain this disparity.
Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.
Blood type may influence response to immune checkpoint inhibitor therapy among patients with metastatic cancer, a study suggests.
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
Load More